Successful conduct of an acute stroke clinical trial during COVID

Jose-Miguel Yamal, Stephanie A Parker, Asha P Jacob, Suja S Rajan, Ritvij Bowry, Patti Bratina, Mengxi Wang, May Nour, Jason Mackey, Sarah Collins, William Jones, Brandi Schimpf, David Ornelas, Ilana Spokoyny, Jenny Fung Im, Greg Gilbert, Michael Eisshofer, James C Grotta, Jose-Miguel Yamal, Stephanie A Parker, Asha P Jacob, Suja S Rajan, Ritvij Bowry, Patti Bratina, Mengxi Wang, May Nour, Jason Mackey, Sarah Collins, William Jones, Brandi Schimpf, David Ornelas, Ilana Spokoyny, Jenny Fung Im, Greg Gilbert, Michael Eisshofer, James C Grotta

Abstract

Most clinical research stopped during COVID due to possible impact on data quality and personnel safety. We aimed to assess the impact of COVID on acute stroke clinical trial conduct at sites that continued to enroll patients during the pandemic. BEST-MSU is an ongoing study of Mobile Stroke Units (MSU) vs standard management of tPA-eligible acute stroke patients in the pre-hospital setting. MSU personnel include a vascular neurologist via telemedicine, and a nurse, CT technologist, paramedics and emergency medicine technicians on-board. During COVID, consent, 90-day modified Rankin Scale (mRS) and EQ5D were obtained by phone instead of in-person, but other aspects of management were similar to the pre-COVID period. We compared patient demographics, study metrics, and infection of study personnel during intra- vs pre-COVID eras. Five of 6 BEST-MSU sites continued to enroll during COVID. There were no differences in intra- (n = 57) vs pre- (n = 869) COVID enrolled tPA eligible patients' age, sex, race (38.6% vs 38.0% Black), ethnicity (15.8% vs 18.6% Hispanic), or NIHSS (median 11 vs 9). The percent of screened patients enrolled and adjudicated tPA eligible declined from 13.6% to 6.6% (p < .001); study enrollment correlated with local stay-at-home and reopening orders. There were no differences in alert to MSU arrival or arrival to tPA times, but MSU on-scene time was 5 min longer (p = .01). There were no differences in ED door to CT, tPA treatment or thrombectomy puncture times, hospital length of stay, discharge disposition, or remote vs in-person 90-day mRS or EQ5D. One MSU nurse tested positive but did not require hospitalization. Clinical research in the pre-hospital setting can be carried out accurately and safely during a pandemic. tPA eligibility rates declined, but otherwise there were no differences in patient demographics, deterioration of study processes, or serious infection of study staff. Trial registration: NCT02190500.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Enrollment in Houston demonstrating a…
Fig 1. Enrollment in Houston demonstrating a decline during COVID stay at home orders, an increase during reopening, and second decline after pause in reopening.
Fig 2. Correlation between hospital discharge and…
Fig 2. Correlation between hospital discharge and 90-day mRS did not differ between in-person and remote assessments.
Points are jittered for visualization.

References

    1. Yamal YM, Rajan SS, Parker SA, Jacob AP, Gonzalez MO, Gonzales NR, et al. Benefits of stroke treatment delivered using a mobile stroke unit trial. Int J Stroke 2017. 10.1177/1747493017711950
    1. Mitchell EJ, Ahmed K, Breeman S, Cotton S, Constable L, Ferry G, et al. It is unprecedented: Trial management during the COVID-19 pandemic and beyond. Trials 2020;21:784 10.1186/s13063-020-04711-6
    1. Gaba P, Bhatt DL. The COVID-19 pandemic: a catalyst to improve clinical trials. Nat Rev Cardiol 2020;17:673–5 10.1038/s41569-020-00439-7
    1. FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency Guidance for Industry, Investigators, and Institutional Review Boards.; 2020
    1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019;50: e344–e418 10.1161/STR.0000000000000211
    1. Wu TC, Parker SA, Jagolino A, Yamal JM, Bowry R, Thomas A, et al. Telemedicine can replace the neurologist on the mobile stroke unit. Stroke 48:493–96, 2017. 10.1161/STROKEAHA.116.015363
    1. Bowry R, Parker SA, Yamal JM, Hwang H, Appana S, Rangel-Guitierrez N, et al. Time to decision and treatment with tPA (tissue-type plasminogen activator) using telemedicine versus an onboard neurologist on a mobile stroke unit. Stroke 2018;49:1528–1530. 10.1161/STROKEAHA.117.020585
    1. Jasne AS, Chojecka P, Maran I, Mageid R, Eldokmak M, Zhang Q, et al. Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic. Stroke 2020;51:2664–2673 10.1161/STR.0000000000000347
    1. Esenwa C, Parides MK, Labovitz DL. The effect of COVID-19 on stroke hospitalizations in New York City. J Stroke and Cerebrovasc Dis 10.1016/j.jstrokecerebrovasdis.2020.105114
    1. Savio K, Pietra GLD, Oddone E, Reggiani M, Leone MA. Reliability of the modified Rankin Scale applied by telephone. Neurol Int. 2013;5:e2 10.4081/ni.2013.e2
    1. Zhanga O, Yangb Y, Saver JL. Discharge destination after acute hospitalization strongly predicts three month disability outcome in ischemic stroke. Restorative Neurology and Neuroscience 2015;33:771–775. 10.3233/RNN-150531

Source: PubMed

3
Iratkozz fel